Gastrointestinal Endoscopy Devices | Medtech 360 | Market Insights | Europe (Supplemental)

Publish date: July 2017

Login to access report

The European GI endoscopy device market will grow moderately through 2025, primarily driven by procedural growth and innovation in the capsule endoscope and Barrett's esophagus ablation device markets. Meanwhile, the ASP for many markets will remain relatively stable due to maturity of the products, slightly limiting market value growth.

This Medtech 360 Report provides key market metrics for the GI endoscopy device market in Europe, including country-level data for major countries and aggregate data for the rest of Europe, across a 10-year period.

Table of contents

  • Europe (Supplemental)
    • Abstract
    • Version History
    • Key Report Updates
    • Gastrointestinal Endoscopy Device Market
      • Market Definitions
        • Geographies Covered
        • Procedures Covered
        • Products Covered
      • Market Forecast Data
    • Gastrointestinal Videoscope System Market
      • Market Definitions
      • Market Forecast Data
    • Capsule Endoscope Market
      • Market Definitions
      • Market Forecast Data
    • Endoscopic Retrograde Cholangiopancreatography Device Market
      • Market Definitions
      • Market Forecast Data
    • Biopsy Device Market
      • Market Definitions
      • Market Forecast Data
    • Retrieval Device Market
      • Market Definitions
      • Market Forecast Data
    • Balloon Dilator Market
      • Market Definitions
      • Market Forecast Data
    • Gastrointestinal Stent Market
      • Market Definitions
      • Market Forecast Data
    • Barrett's Esophagus Ablation Device Market
      • Market Definitions
      • Market Forecast Data
    • Hemostasis Device Market
      • Market Definitions
      • Market Forecast Data
    • Enteral Feeding Device Market
      • Market Definitions
      • Market Forecast Data
    • Appendix
      • Abbreviations

Author(s): Paul Desormeaux, MSc

Paul Desormeaux is a senior analyst within the Endoscopy and Aesthetics Medtech Insights team at Decision Resources Group, specializing in the fields of neurosurgery, neurostimulation, gastroenterology, obesity, diabetes, and regenerative medicine. He has authored and presented a number of thought leadership pieces on the opioid crisis, the growing diabetes epidemic, and the current state of health care in the US. Paul holds a Bachelor's degree from Queen’s University and a Master's degree in Biochemistry from the University of Western Ontario.